Global Clinical Research Services (CRS) Market Growth (Status and Outlook) 2023-2029

Global Clinical Research Services (CRS) Market Growth (Status and Outlook) 2023-2029

This clinical research services procurement research report offers a predictive analysis of the critical cost drivers and the current supply market trends that will facilitate a better understanding of the market from the cost perspective.

The offset of chronic ailments, increase in aging demography, and augmented spend potential are paving the way for the development of newer drugs and treatments. Consequently, the pharmaceutical industry is increasing their adoption of various clinical research services to develop new drugs while the healthcare industry is seeking services to make the treatments more affordable.

LPI (LP Information)' newest research report, the “Clinical Research Services (CRS) Industry Forecast” looks at past sales and reviews total world Clinical Research Services (CRS) sales in 2022, providing a comprehensive analysis by region and market sector of projected Clinical Research Services (CRS) sales for 2023 through 2029. With Clinical Research Services (CRS) sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Clinical Research Services (CRS) industry.

This Insight Report provides a comprehensive analysis of the global Clinical Research Services (CRS) landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Clinical Research Services (CRS) portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Clinical Research Services (CRS) market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Clinical Research Services (CRS) and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Clinical Research Services (CRS).

The global Clinical Research Services (CRS) market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Clinical Research Services (CRS) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Clinical Research Services (CRS) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Clinical Research Services (CRS) is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Clinical Research Services (CRS) players cover Labcorp, IQVIA, Syneos Health, Parexel, PRA, PPD, CRL and ICON, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Clinical Research Services (CRS) market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Early Phase Services
Late Phase Services
Other Services

Segmentation by application
Cancer
Cardiovascular
CNS
Infectious Diseases
Metabolic Diseases
Other Diseases

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Labcorp
IQVIA
Syneos Health
Parexel
PRA
PPD
CRL
ICON

Please note: The report will take approximately 2 business days to prepare and deliver.